Global Poliovirus Vaccine Inactivated Market Research Report 2025(Status and Outlook)

March 2025 | 198 pages | ID: GBAF5F3418A3EN
Bosson Research

Abstracts

Report Overview

Inactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.

This report provides a deep insight into the global Poliovirus Vaccine Inactivated market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Poliovirus Vaccine Inactivated Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Poliovirus Vaccine Inactivated market in any manner.

Global Poliovirus Vaccine Inactivated Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sanofi

GSK

Serum Institute (Bilthoven Biologicals)

IMBCA

Market Segmentation (by Type)

Human Diploid Cell

Monkey Kidney Cell

Market Segmentation (by Application)

Public

Private

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Poliovirus Vaccine Inactivated Market
• Overview of the regional outlook of the Poliovirus Vaccine Inactivated Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Poliovirus Vaccine Inactivated Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Poliovirus Vaccine Inactivated
1.2 Key Market Segments
1.2.1 Poliovirus Vaccine Inactivated Segment by Type
1.2.2 Poliovirus Vaccine Inactivated Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Poliovirus Vaccine Inactivated Market Overview
2.1 Global Market Overview
2.1.1 Global Poliovirus Vaccine Inactivated Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Poliovirus Vaccine Inactivated Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Poliovirus Vaccine Inactivated Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Poliovirus Vaccine Inactivated Product Life Cycle
3.3 Global Poliovirus Vaccine Inactivated Sales by Manufacturers (2020-2025)
3.4 Global Poliovirus Vaccine Inactivated Revenue Market Share by Manufacturers (2020-2025)
3.5 Poliovirus Vaccine Inactivated Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Poliovirus Vaccine Inactivated Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Poliovirus Vaccine Inactivated Manufacturing Sites, Area Served, Product Type
3.8 Poliovirus Vaccine Inactivated Market Competitive Situation and Trends
3.8.1 Poliovirus Vaccine Inactivated Market Concentration Rate
3.8.2 Global 5 and 10 Largest Poliovirus Vaccine Inactivated Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Poliovirus Vaccine Inactivated Industry Chain Analysis
4.1 Poliovirus Vaccine Inactivated Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Poliovirus Vaccine Inactivated Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Poliovirus Vaccine Inactivated Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Poliovirus Vaccine Inactivated Market
5.7 ESG Ratings of Leading Companies
6 Global Poliovirus Vaccine Inactivated Market by Region
6.1 Global Poliovirus Vaccine Inactivated Market Size by Region
6.1.1 Global Poliovirus Vaccine Inactivated Market Size by Region
6.1.2 Global Poliovirus Vaccine Inactivated Market Size Market Share by Region
6.2 Global Poliovirus Vaccine Inactivated Sales by Region
6.2.1 Global Poliovirus Vaccine Inactivated Sales by Region
6.2.2 Global Poliovirus Vaccine Inactivated Sales Market Share by Region
7 North America Market Overview
7.1 North America Poliovirus Vaccine Inactivated Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Poliovirus Vaccine Inactivated Market Size by Type
7.3 North America Poliovirus Vaccine Inactivated Market Size by Application
8 Europe Market Overview
8.1 Europe Poliovirus Vaccine Inactivated Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Poliovirus Vaccine Inactivated Market Size by Type
8.3 Europe Poliovirus Vaccine Inactivated Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Poliovirus Vaccine Inactivated Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Poliovirus Vaccine Inactivated Market Size by Type
9.3 Asia-Pacific Poliovirus Vaccine Inactivated Market Size by Application
10 South America Market Overview
10.1 South America Poliovirus Vaccine Inactivated Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Poliovirus Vaccine Inactivated Market Size by Type
10.3 South America Poliovirus Vaccine Inactivated Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Poliovirus Vaccine Inactivated Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Poliovirus Vaccine Inactivated Market Size by Type
11.3 Middle East and Africa Poliovirus Vaccine Inactivated Market Size by Application
12 Poliovirus Vaccine Inactivated Market Production by Region
12.1 Global Production of Poliovirus Vaccine Inactivated by Region(2020-2025)
12.2 Global Poliovirus Vaccine Inactivated Revenue Market Share by Region (2020-2025)
12.3 Global Poliovirus Vaccine Inactivated Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Poliovirus Vaccine Inactivated Production
12.4.1 North America Poliovirus Vaccine Inactivated Production Growth Rate (2020-2025)
12.4.2 North America Poliovirus Vaccine Inactivated Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Poliovirus Vaccine Inactivated Production
12.5.1 Europe Poliovirus Vaccine Inactivated Production Growth Rate (2020-2025)
12.5.2 Europe Poliovirus Vaccine Inactivated Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Poliovirus Vaccine Inactivated Production (2020-2025)
12.6.1 Japan Poliovirus Vaccine Inactivated Production Growth Rate (2020-2025)
12.6.2 Japan Poliovirus Vaccine Inactivated Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Poliovirus Vaccine Inactivated Production (2020-2025)
12.7.1 China Poliovirus Vaccine Inactivated Production Growth Rate (2020-2025)
12.7.2 China Poliovirus Vaccine Inactivated Production, Revenue, Price and Gross Margin (2020-2025)
13 Poliovirus Vaccine Inactivated Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Poliovirus Vaccine Inactivated Sales Market Share by Type (2020-2033)
13.3 Global Poliovirus Vaccine Inactivated Market Size Market Share by Type (2020-2033)
13.4 Global Poliovirus Vaccine Inactivated Price by Type (2020-2033)
14 Poliovirus Vaccine Inactivated Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Poliovirus Vaccine Inactivated Market Sales by Application (2020-2033)
14.3 Global Poliovirus Vaccine Inactivated Market Size (M USD) by Application (2020-2033)
14.4 Global Poliovirus Vaccine Inactivated Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Sanofi
15.1.1 Sanofi Basic Information
15.1.2 Sanofi Poliovirus Vaccine Inactivated Product Overview
15.1.3 Sanofi Poliovirus Vaccine Inactivated Product Market Performance
15.1.4 Sanofi Business Overview
15.1.5 Sanofi SWOT Analysis
15.1.6 Sanofi Recent Developments
15.2 GSK
15.2.1 GSK Basic Information
15.2.2 GSK Poliovirus Vaccine Inactivated Product Overview
15.2.3 GSK Poliovirus Vaccine Inactivated Product Market Performance
15.2.4 GSK Business Overview
15.2.5 GSK SWOT Analysis
15.2.6 GSK Recent Developments
15.3 Serum Institute (Bilthoven Biologicals)
15.3.1 Serum Institute (Bilthoven Biologicals) Basic Information
15.3.2 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Overview
15.3.3 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Market Performance
15.3.4 Serum Institute (Bilthoven Biologicals) Business Overview
15.3.5 Serum Institute (Bilthoven Biologicals) SWOT Analysis
15.3.6 Serum Institute (Bilthoven Biologicals) Recent Developments
15.4 IMBCA
15.4.1 IMBCA Basic Information
15.4.2 IMBCA Poliovirus Vaccine Inactivated Product Overview
15.4.3 IMBCA Poliovirus Vaccine Inactivated Product Market Performance
15.4.4 IMBCA Business Overview
15.4.5 IMBCA Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Poliovirus Vaccine Inactivated Market Size by Type (M USD)
Table 4. Global Poliovirus Vaccine Inactivated Market Size by Application (M USD)
Table 5. Poliovirus Vaccine Inactivated Market Size Comparison by Region (M USD)
Table 6. Global Poliovirus Vaccine Inactivated Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Poliovirus Vaccine Inactivated Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Poliovirus Vaccine Inactivated Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Poliovirus Vaccine Inactivated Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliovirus Vaccine Inactivated as of 2024)
Table 11. Global Market Poliovirus Vaccine Inactivated Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Poliovirus Vaccine Inactivated Manufacturing Sites and Area Served
Table 13. Manufacturers Poliovirus Vaccine Inactivated Product Type
Table 14. Global Poliovirus Vaccine Inactivated Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Poliovirus Vaccine Inactivated Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Poliovirus Vaccine Inactivated Market Size Comparison by Region (M USD)
Table 26. Global Poliovirus Vaccine Inactivated Market Size by Region (2020-2033) & (M USD)
Table 27. Global Poliovirus Vaccine Inactivated Market Size Market Share by Region (2020-2033)
Table 28. Global Poliovirus Vaccine Inactivated Sales by Region (2020-2033) & (K MT)
Table 29. Global Poliovirus Vaccine Inactivated Sales Market Share by Region (2020-2033)
Table 30. North America Poliovirus Vaccine Inactivated Market Size by Country (2020-2033) & (M USD)
Table 31. North America Poliovirus Vaccine Inactivated Sales by Country (2020-2033) & (K MT)
Table 32. North America Poliovirus Vaccine Inactivated Sales by Type (K MT)
Table 33. North America Poliovirus Vaccine Inactivated Market Size by Type (M USD)
Table 34. North America Poliovirus Vaccine Inactivated Sales (K MT) by Type (2020-2033)
Table 35. North America Poliovirus Vaccine Inactivated Market Size (M USD) by Type (2020-2033)
Table 36. North America Poliovirus Vaccine Inactivated Sales by Application (K MT)
Table 37. North America Poliovirus Vaccine Inactivated Market Size by Application (M USD)
Table 38. North America Poliovirus Vaccine Inactivated Sales (K MT) by Application (2020-2033)
Table 39. North America Poliovirus Vaccine Inactivated Market Size (M USD) by Application (2020-2033)
Table 40. Europe Poliovirus Vaccine Inactivated Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Poliovirus Vaccine Inactivated Sales by Country (2020-2033) & (K MT)
Table 42. Europe Poliovirus Vaccine Inactivated Sales by Type (K MT)
Table 43. Europe Poliovirus Vaccine Inactivated Market Size by Type (M USD)
Table 44. Europe Poliovirus Vaccine Inactivated Sales (K MT) by Type (2020-2033)
Table 45. Europe Poliovirus Vaccine Inactivated Market Size (M USD) by Type (2020-2033)
Table 46. Europe Poliovirus Vaccine Inactivated Sales by Application (K MT)
Table 47. Europe Poliovirus Vaccine Inactivated Market Size by Application (M USD)
Table 48. Europe Poliovirus Vaccine Inactivated Sales (K MT) by Application (2020-2033)
Table 49. Europe Poliovirus Vaccine Inactivated Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Poliovirus Vaccine Inactivated Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Poliovirus Vaccine Inactivated Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Poliovirus Vaccine Inactivated Sales by Type (K MT)
Table 53. Asia-Pacific Poliovirus Vaccine Inactivated Market Size by Type (M USD)
Table 54. Asia-Pacific Poliovirus Vaccine Inactivated Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Poliovirus Vaccine Inactivated Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Poliovirus Vaccine Inactivated Sales by Application (K MT)
Table 57. Asia-Pacific Poliovirus Vaccine Inactivated Market Size by Application (M USD)
Table 58. Asia-Pacific Poliovirus Vaccine Inactivated Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Poliovirus Vaccine Inactivated Market Size (M USD) by Application (2020-2025)
Table 60. South America Poliovirus Vaccine Inactivated Market Size by Country (2020-2033) & (M USD)
Table 61. South America Poliovirus Vaccine Inactivated Sales by Country (2020-2033) & (K MT)
Table 62. South America Poliovirus Vaccine Inactivated Sales by Type (K MT)
Table 63. South America Poliovirus Vaccine Inactivated Market Size by Type (M USD)
Table 64. South America Poliovirus Vaccine Inactivated Sales (K MT) by Type (2020-2033)
Table 65. South America Poliovirus Vaccine Inactivated Market Size (M USD) by Type (2020-2033)
Table 66. South America Poliovirus Vaccine Inactivated Sales by Application (K MT)
Table 67. South America Poliovirus Vaccine Inactivated Market Size by Application (M USD)
Table 68. South America Poliovirus Vaccine Inactivated Sales (K MT) by Application (2020-2033)
Table 69. South America Poliovirus Vaccine Inactivated Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Poliovirus Vaccine Inactivated Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Poliovirus Vaccine Inactivated Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Poliovirus Vaccine Inactivated Sales by Type (K MT)
Table 73. Middle East and Africa Poliovirus Vaccine Inactivated Market Size by Type (M USD)
Table 74. Middle East and Africa Poliovirus Vaccine Inactivated Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Poliovirus Vaccine Inactivated Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Poliovirus Vaccine Inactivated Sales by Application (K MT)
Table 77. Middle East and Africa Poliovirus Vaccine Inactivated Market Size by Application (M USD)
Table 78. Middle East and Africa Poliovirus Vaccine Inactivated Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Poliovirus Vaccine Inactivated Market Size (M USD) by Application (2020-2033)
Table 80. Global Poliovirus Vaccine Inactivated Production (K MT) by Region(2020-2025)
Table 81. Global Poliovirus Vaccine Inactivated Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Poliovirus Vaccine Inactivated Revenue Market Share by Region (2020-2025)
Table 83. Global Poliovirus Vaccine Inactivated Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Poliovirus Vaccine Inactivated Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Poliovirus Vaccine Inactivated Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Poliovirus Vaccine Inactivated Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Poliovirus Vaccine Inactivated Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Poliovirus Vaccine Inactivated Sales by Type (K MT)
Table 89. Global Poliovirus Vaccine Inactivated Market Size by Type (M USD)
Table 90. Global Poliovirus Vaccine Inactivated Sales (K MT) by Type (2020-2033)
Table 91. Global Poliovirus Vaccine Inactivated Sales Market Share by Type (2020-2033)
Table 92. Global Poliovirus Vaccine Inactivated Market Size (M USD) by Type (2020-2033)
Table 93. Global Poliovirus Vaccine Inactivated Market Size Share by Type (2020-2033)
Table 94. Global Poliovirus Vaccine Inactivated Sales (K MT) by Application
Table 95. Global Poliovirus Vaccine Inactivated Market Size by Application(M USD)
Table 96. Global Poliovirus Vaccine Inactivated Sales by Application (2020-2033) & (K MT)
Table 97. Global Poliovirus Vaccine Inactivated Sales Market Share by Application (2020-2033)
Table 98. Global Poliovirus Vaccine Inactivated Market Size by Application (2020-2033) & (M USD)
Table 99. Global Poliovirus Vaccine Inactivated Market Share by Application (2020-2033)
Table 100. Global Poliovirus Vaccine Inactivated Sales Growth Rate by Application (2020-2033)
Table 101. Sanofi Basic Information
Table 102. Sanofi Poliovirus Vaccine Inactivated Product Overview
Table 103. Sanofi Poliovirus Vaccine Inactivated Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Sanofi Business Overview
Table 105. Sanofi SWOT Analysis
Table 106. Sanofi Recent Developments
Table 107. GSK Basic Information
Table 108. GSK Poliovirus Vaccine Inactivated Product Overview
Table 109. GSK Poliovirus Vaccine Inactivated Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. GSK Business Overview
Table 111. GSK SWOT Analysis
Table 112. GSK Recent Developments
Table 113. Serum Institute (Bilthoven Biologicals) Basic Information
Table 114. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Overview
Table 115. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Serum Institute (Bilthoven Biologicals) Business Overview
Table 117. Serum Institute (Bilthoven Biologicals) SWOT Analysis
Table 118. Serum Institute (Bilthoven Biologicals) Recent Developments
Table 119. IMBCA Basic Information
Table 120. IMBCA Poliovirus Vaccine Inactivated Product Overview
Table 121. IMBCA Poliovirus Vaccine Inactivated Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. IMBCA Business Overview
Table 123. IMBCA Recent Developments
List of Figures
Figure 1. Product Picture of Poliovirus Vaccine Inactivated
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Poliovirus Vaccine Inactivated Market Size (M USD), 2024-2033
Figure 5. Global Poliovirus Vaccine Inactivated Market Size (M USD) (2020-2033)
Figure 6. Global Poliovirus Vaccine Inactivated Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Poliovirus Vaccine Inactivated Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Poliovirus Vaccine Inactivated Product Life Cycle
Figure 13. Poliovirus Vaccine Inactivated Sales Share by Manufacturers in 2024
Figure 14. Global Poliovirus Vaccine Inactivated Revenue Share by Manufacturers in 2024
Figure 15. Poliovirus Vaccine Inactivated Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Poliovirus Vaccine Inactivated Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Poliovirus Vaccine Inactivated Revenue in 2024
Figure 18. Industry Chain Map of Poliovirus Vaccine Inactivated
Figure 19. Global Poliovirus Vaccine Inactivated Market PEST Analysis
Figure 20. Global Poliovirus Vaccine Inactivated Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Poliovirus Vaccine Inactivated Market Size by Region
Figure 27. Global Poliovirus Vaccine Inactivated Market Size Market Share by Region (2020-2033)
Figure 28. Global Poliovirus Vaccine Inactivated Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Poliovirus Vaccine Inactivated Market Size (M USD) by Country
Figure 33. USA Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Poliovirus Vaccine Inactivated Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Poliovirus Vaccine Inactivated Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Poliovirus Vaccine Inactivated Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Poliovirus Vaccine Inactivated Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Poliovirus Vaccine Inactivated Market Size (M USD)by Type
Figure 40. North America Poliovirus Vaccine Inactivated Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Poliovirus Vaccine Inactivated Market Size (M USD) by Country
Figure 45. Germany Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Poliovirus Vaccine Inactivated Market Size (M USD) by Type
Figure 56. Europe Poliovirus Vaccine Inactivated Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Poliovirus Vaccine Inactivated Market Size (M USD) by Country
Figure 61. China Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Poliovirus Vaccine Inactivated Market Size (M USD) by Type
Figure 72. Asia-Pacific Poliovirus Vaccine Inactivated Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Poliovirus Vaccine Inactivated Market Size (M USD) by Country
Figure 77. Brazil Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Poliovirus Vaccine Inactivated Market Size (M USD) by Type
Figure 84. South America Poliovirus Vaccine Inactivated Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Poliovirus Vaccine Inactivated Market Size (M USD) by Country
Figure 89. Saudi Arabia Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Poliovirus Vaccine Inactivated Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Poliovirus Vaccine Inactivated Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Poliovirus Vaccine Inactivated Market Size (M USD) by Type
Figure 100. Middle East and Africa Poliovirus Vaccine Inactivated Market Size (M USD) by Application
Figure 101. Global Poliovirus Vaccine Inactivated Production Market Share by Region (2020-2025)
Figure 102. North America Poliovirus Vaccine Inactivated Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Poliovirus Vaccine Inactivated Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Poliovirus Vaccine Inactivated Production (K MT) Growth Rate (2020-2025)
Figure 105. China Poliovirus Vaccine Inactivated Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Poliovirus Vaccine Inactivated Market Size by Type (M USD)
Figure 108. Sales Market Share of Poliovirus Vaccine Inactivated by Type (2020-2033)
Figure 109. Sales Market Share of Poliovirus Vaccine Inactivated by Type in 2024
Figure 110. Market Size Share of Poliovirus Vaccine Inactivated by Type (2020-2033)
Figure 111. Market Size Share of Poliovirus Vaccine Inactivated by Type in 2024
Figure 112. Global Poliovirus Vaccine Inactivated Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Poliovirus Vaccine Inactivated Market Size by Application(M USD)
Figure 115. Global Poliovirus Vaccine Inactivated Market Share by Application
Figure 116. Global Poliovirus Vaccine Inactivated Sales Market Share by Application (2020-2033)
Figure 117. Global Poliovirus Vaccine Inactivated Sales Market Share by Application in 2024
Figure 118. Global Poliovirus Vaccine Inactivated Market Share by Application (2020-2033)
Figure 119. Global Poliovirus Vaccine Inactivated Market Share by Application in 2024
Figure 120. Global Poliovirus Vaccine Inactivated Sales Growth Rate by Application (2020-2033)